Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Regenicin Inc (RGIN)

Regenicin Inc (RGIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Regenicin Inc 10 HIGH COURT LITTLE FALLS NJ 07424 USA

www.regenicin.com P: 973-557-8914

Description:

Regenicin, Inc is a development stage biotechnology company primarily focused on the development of regenerative cell therapies to restore the health of damaged tissues and organs. The Company's product candidate includes PermaDerm that uses the patient's own skin cells to generate living, tissue-engineered skin for the treatment of chronic burns and wounds. The candidate uses biomedical polymer to act as a connective agent in the skin generation process. The Company's prime focus is development of therapeutics in the areas of diabetes, chronic wounds, including ulcers, adult stem cell therapies and reconstructive surgery applications. Regenicin, Inc is headquartered in New York, New York.

Key Statistics

Overview:

Market Capitalization, $K 829
Enterprise Value, $K 1,289
Shares Outstanding, K 165,770
Annual Sales, $ 0 K
Annual Net Income, $ -640 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -340 K
EBIT, $ -900 K
EBITDA, $ -900 K
% of Institutional Shareholders 0.01%
Float, K 165,770
% Float 100.00%
Short Volume Ratio 0.54

Growth:

1-Year Return 4,900.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/12/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RGIN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -0.08
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -15.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar